These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27693441)

  • 1. Interventions for age-related diseases: Shifting the paradigm.
    Figueira I; Fernandes A; Mladenovic Djordjevic A; Lopez-Contreras A; Henriques CM; Selman C; Ferreiro E; Gonos ES; Trejo JL; Misra J; Rasmussen LJ; Xapelli S; Ellam T; Bellantuono I
    Mech Ageing Dev; 2016 Dec; 160():69-92. PubMed ID: 27693441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of geroprotectors to prevent multimorbidity: Opportunities and challenges.
    Morsli S; Bellantuono I
    Mech Ageing Dev; 2021 Jan; 193():111391. PubMed ID: 33144142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms.
    Tchkonia T; Palmer AK; Kirkland JL
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1481-e1487. PubMed ID: 33155651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological ageing with HIV infection: evaluating the geroscience hypothesis.
    Montano M; Oursler KK; Xu K; Sun YV; Marconi VC
    Lancet Healthy Longev; 2022 Mar; 3(3):e194-e205. PubMed ID: 36092375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frailty, a multisystem ageing syndrome.
    Thillainadesan J; Scott IA; Le Couteur DG
    Age Ageing; 2020 Aug; 49(5):758-763. PubMed ID: 32542377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of development of multimorbidity in the elderly.
    Barnes PJ
    Eur Respir J; 2015 Mar; 45(3):790-806. PubMed ID: 25614163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geroprotectors and Skeletal Health: Beyond the Headlines.
    Rayson A; Boudiffa M; Naveed M; Griffin J; Dall'Ara E; Bellantuono I
    Front Cell Dev Biol; 2022; 10():682045. PubMed ID: 35223825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization.
    Kulkarni AS; Aleksic S; Berger DM; Sierra F; Kuchel GA; Barzilai N
    Aging Cell; 2022 Apr; 21(4):e13596. PubMed ID: 35343051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases.
    Kubben N; Misteli T
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):595-609. PubMed ID: 28792007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging with multimorbidity: a systematic review of the literature.
    Marengoni A; Angleman S; Melis R; Mangialasche F; Karp A; Garmen A; Meinow B; Fratiglioni L
    Ageing Res Rev; 2011 Sep; 10(4):430-9. PubMed ID: 21402176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geroscience and the trans-NIH Geroscience Interest Group, GSIG.
    Sierra F; Kohanski R
    Geroscience; 2017 Feb; 39(1):1-5. PubMed ID: 28299635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity.
    Seals DR; Justice JN; LaRocca TJ
    J Physiol; 2016 Apr; 594(8):2001-24. PubMed ID: 25639909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating age-related multimorbidity: the drug discovery challenge.
    Ermogenous C; Green C; Jackson T; Ferguson M; Lord JM
    Drug Discov Today; 2020 Aug; 25(8):1403-1415. PubMed ID: 32574698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.
    Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M
    BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frailty-A promising concept to evaluate disease vulnerability.
    Ribeiro AR; Howlett SE; Fernandes A
    Mech Ageing Dev; 2020 Apr; 187():111217. PubMed ID: 32088282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long terms trends of multimorbidity and association with physical activity in older English population.
    Dhalwani NN; O'Donovan G; Zaccardi F; Hamer M; Yates T; Davies M; Khunti K
    Int J Behav Nutr Phys Act; 2016 Jan; 13():8. PubMed ID: 26785753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
    Hasan Ibrahim AS; Barry HE; Hughes CM
    Fam Pract; 2021 Jul; 38(4):509-523. PubMed ID: 33506870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.